Conventional dose CRRT is one of 50 small molecule programs targeting Acute Kidney Injury. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
92 competitors in Acute Kidney Injury
Zyloprim
Glypressin
Giapreza
Oraverse
Lamisil
Northera
Desferal
Pitressin
Arginine Vasopressin
Jardiance
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details